Gibson Chris Aih2019

Christopher Gibson

Co-Founder and CEO, Recursion Pharmaceuticals

Christopher Gibson is co-founder and CEO of Recursion Pharmaceuticals, a clinical-stage biopharma company leveraging the latest in automation, artificial intelligence, biology, and chemistry to discover new medicines at scale. In 2013, he completed his PhD at the University of Utah, where he trained with Recursion co-founder Dean Li, then took a leave of absence from medical school to start and grow the company. Gibson is a board member of CureHHT, a patient advocacy group for Hereditary Hemorrhagic Telangiectasia, and a member of the Rare and Undiagnosed Network Advisory Board. Holding undergraduate degrees in bioengineering and managerial studies, he completed an entrepreneurship course at Stanford Graduate School of Business.

Thank you for signing up!

Please provide a valid email address.

Please provide a valid email address.
aerial 2019 campus
Sign up to receive the latest news from Aspen Ideas.